Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantation

Journal of Clinical Pharmacy and Therapeutics

Volumn 34, Issue 5, 2009, Pages 539-545

  Sugiyama, K ^a   Isogai, K ^a   Toyama, A ^a   Satoh, H ^a   Saito, K ^b   Nakagawa, Y ^b   Tasaki, M ^b   Takahashi, K ^b   Saito, N ^c   Hirano, T ^d  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b Division of Urology   (United States)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^d TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyl tetrazolium bromide; Cyclosporine; Cytomegalovirus; Immunosuppressive therapy; Lymphocyte immunosuppressant sensitivity test; Peripheral blood mononuclear cells; Renal transplantation

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TETRAZOLIUM;

ACUTE GRAFT REJECTION; ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; GRAFT FAILURE; HUMAN; HUMAN CELL; IC 50; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LYMPHOCYTE; LYMPHOCYTE IMMUNOSUPPRESSANT SENSITIVITY TEST; MALE; MEDICAMENTOSUS HEPATOPATHY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD;

ADULT; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 70049115322     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01036.x     Document Type: Article

References (15)

1. 2 monitoring: a review. Transplantation, 73, S3 S11.
2. Hirano T, Oka K, Takeuchi H, Sakurai E, Matsuno N, Tamaki T, Kozaki M (1994) Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone. Transplantation, 57, 1341 1348.
3. Bouma GJ, Hollander DA, van der Meer-Prins EM, van Bree SP, van Rood JJ, van der Woude FJ, Claas FH (1996) In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation, 62, 1422 1429.
4. Francis DM, Dumble LJ, Bowes L, Clunie GJ, Macdonald IM (1988) Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. Transplantation, 46, 853 857.
5. Sugiyama K, Satoh H, Saito K, Takahashi K, Saito N, Hirano T (2005) Immunosuppressive efficacy of mycophenolate mofetil when compared with azathioprine and mizoribine against peripheral lymphocytes from renal transplant recipients. Transplant International, 18, 590 595.
6. Takeuchi H, Hirano T, Oka K et al. (1998) Lymphocyte sensitivity to cyclosporine and tacrolimus in chronic renal failure patients and clinical significance in renal transplantation. Transplantation Proceedings, 30, 36 39.
7. Sugiyama K, Arakawa K, Satoh H, Saito K, Takahashi K, Saito N, Hirano T (2006) Correlation between pharmacological efficacy of cyclosporine A and tacrolimus, evaluated by lymphocyte immunosuppressant-sensitivity test (LIST) with MTT assay procedure in renal transplant recipients. Journal of Immunoassay & Immumochemistry, 27, 195 205.
8. Hirano T, Oka K, Takeuchi H et al. (1997) Immunosuppressant pharmacodymamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis and psoriasis: possible implications for individual therapeutic efficacy. Clinical Pharmacology and Therapeutics, 62, 652 664.
9. Hirano T, Abe K, Gotoh M, Oka K (1995) Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. British Journal of Cancer, 72, 1380 1388.
10. Sugiyama K, Kawada T, Satoh H, Hirano T (2001) Comparison of suppressive potency between prednisolone and prednisolone sodium succinate against mitogen-induced blastogenesis of human peripheral blood mononuclear cells in-vitro. Journal of Pharmacy and Pharmacology, 53, 727 733.
11. Sugiyama K, Satoh H, Hirano T (2003) Comparison of suppressive potency between azathioprine and 6-mercaputopurine against mitogen-induced blastogenesis of human peripheral blood mononuclear cells in-vitro. Journal of Pharmacy and Pharmacology, 55, 393 398.
12. Flechner SM, Goldfarb D, Modlin C et al. (2002) Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine. Transplantation, 74, 1070 1076.
13. Rostaing L, Puyoo O, Tkaczuk J et al. (1999) Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. Clinical Transplantation, 13, 400 409.
14. Grunewald RW, Fiedler GM, Stock B, Grunewald JM, Muller GA (2000) Soluble CD-4 and CD-8 as markers of immunological activation in renal transplant recipients. Nephrology, Dialysis, Transplantation, 15, 71 77.
15. Kyo M, Ichikawa T, Toki K et al. (2002) Differential diagnosis of kidney transplant rejection and cyclosporin/tacrolimus nephropathy using urine cytology. Clinical Transplantation, 16 (Suppl 8 40 44.